818 related articles for article (PubMed ID: 26537358)
21. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
22. First-year GFR slope and long-term renal outcome in IgA nephropathy.
Lee K; Shin J; Park J; Hwang S; Jang HR; Huh W; Kwon GY; Kim YG; Oh HY; Lee JE; Kim DJ
Eur J Clin Invest; 2018 Jun; 48(6):e12936. PubMed ID: 29660832
[TBL] [Abstract][Full Text] [Related]
23. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
24. Crescentic IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
[TBL] [Abstract][Full Text] [Related]
25. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Characteristics, Role of Immunosuppressive Therapy and Progression in IgA Nephropathy with Hyperuricemia.
Ruan Y; Hong F; Wu J; Lin M; Wang C; Lian F; Cao F; Yang G; Gao M
Kidney Blood Press Res; 2018; 43(4):1131-1140. PubMed ID: 30016775
[TBL] [Abstract][Full Text] [Related]
27. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Mariani LH; Bomback AS; Canetta PA; Flessner MF; Helmuth M; Hladunewich MA; Hogan JJ; Kiryluk K; Nachman PH; Nast CC; Rheault MN; Rizk DV; Trachtman H; Wenderfer SE; Bowers C; Hill-Callahan P; Marasa M; Poulton CJ; Revell A; Vento S; Barisoni L; Cattran D; D'Agati V; Jennette JC; Klein JB; Laurin LP; Twombley K; Falk RJ; Gharavi AG; Gillespie BW; Gipson DS; Greenbaum LA; Holzman LB; Kretzler M; Robinson B; Smoyer WE; Guay-Woodford LM;
Am J Kidney Dis; 2019 Feb; 73(2):218-229. PubMed ID: 30420158
[TBL] [Abstract][Full Text] [Related]
28. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
29. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
30. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
Zhang Y; Sun L; Zhou S; Xu Q; Xu Q; Liu D; Liu L; Hu R; Quan S; Xing G
Kidney Blood Press Res; 2018; 43(2):639-650. PubMed ID: 29698975
[TBL] [Abstract][Full Text] [Related]
31. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
[TBL] [Abstract][Full Text] [Related]
32. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
[TBL] [Abstract][Full Text] [Related]
33. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
Donadio JV; Bergstralh EJ; Grande JP; Rademcher DM
Nephrol Dial Transplant; 2002 Jul; 17(7):1197-203. PubMed ID: 12105241
[TBL] [Abstract][Full Text] [Related]
34. Cigarette smoking may accelerate the progression of IgA nephropathy.
Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
[TBL] [Abstract][Full Text] [Related]
35. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
[TBL] [Abstract][Full Text] [Related]
36. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
[TBL] [Abstract][Full Text] [Related]
38. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.
Tanaka S; Ninomiya T; Masutani K; Nagata M; Tsuchimoto A; Tsuruya K; Kitazono T
Clin Exp Nephrol; 2015 Dec; 19(6):1062-70. PubMed ID: 25700934
[TBL] [Abstract][Full Text] [Related]
40. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
